These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 3665923)

  • 1. Two hydrophobic low-molecular-mass protein fractions of pulmonary surfactant. Characterization and biophysical activity.
    Curstedt T; Jörnvall H; Robertson B; Bergman T; Berggren P
    Eur J Biochem; 1987 Oct; 168(2):255-62. PubMed ID: 3665923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative studies on the biophysical activities of the low-molecular-weight hydrophobic proteins purified from bovine pulmonary surfactant.
    Yu SH; Possmayer F
    Biochim Biophys Acta; 1988 Aug; 961(3):337-50. PubMed ID: 3401500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of the low-molecular weight (less than or equal to 15,000 daltons) apoproteins of pulmonary surfactant.
    Suzuki Y; Curstedt T; Grossmann G; Kobayashi T; Nilsson R; Nohara K; Robertson B
    Eur J Respir Dis; 1986 Nov; 69(5):336-45. PubMed ID: 3792469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the small hydrophobic proteins associated with pulmonary surfactant.
    Yu SH; Chung W; Olafson RW; Harding PG; Possmayer F
    Biochim Biophys Acta; 1987 Oct; 921(3):437-48. PubMed ID: 3663690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biophysical inhibition of synthetic vs. naturally-derived pulmonary surfactant preparations by polymeric nanoparticles.
    Beck-Broichsitter M; Ruppert C; Schmehl T; Günther A; Seeger W
    Biochim Biophys Acta; 2014 Jan; 1838(1 Pt B):474-81. PubMed ID: 24184425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physiological activity of pulmonary surfactant with low protein content: effect of enrichment with synthetic phospholipids.
    Berggren P; Curstedt T; Grossman G; Nilsson R; Robertson B
    Exp Lung Res; 1985; 8(1):29-51. PubMed ID: 3846531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biophysical activity of an artificial surfactant containing an analogue of surfactant protein (SP)-C and native SP-B.
    Palmblad M; Johansson J; Robertson B; Curstedt T
    Biochem J; 1999 Apr; 339 ( Pt 2)(Pt 2):381-6. PubMed ID: 10191270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of human surfactant low molecular weight apoproteins in the reconstitution of surfactant biologic activity.
    Revak SD; Merritt TA; Degryse E; Stefani L; Courtney M; Hallman M; Cochrane CG
    J Clin Invest; 1988 Mar; 81(3):826-33. PubMed ID: 3343343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reconstitution of surfactant activity using purified human apoprotein and phospholipids measured in vitro and in vivo.
    Revak SD; Merritt TA; Hallman M; Cochrane CG
    Am Rev Respir Dis; 1986 Dec; 134(6):1258-65. PubMed ID: 3789526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exogenous porcine surfactant (Curosurf) is inactivated by monoclonal antibody to the surfactant-associated hydrophobic protein SP-B.
    Kobayashi T; Robertson B; Grossmann G; Nitta K; Curstedt T; Suzuki Y
    Acta Paediatr; 1992 Sep; 81(9):665-71. PubMed ID: 1421904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biophysical activity of synthetic phospholipids combined with purified lung surfactant 6000 dalton apoprotein.
    Notter RH; Shapiro DL; Ohning B; Whitsett JA
    Chem Phys Lipids; 1987 Jun; 44(1):1-17. PubMed ID: 3607971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of reconstituted pulmonary surfactant containing the 6000-dalton hydrophobic protein on lung compliance of prematurely delivered rabbit fetuses.
    Yu SH; Wallace D; Bhavnani B; Enhorning G; Harding PG; Possmayer F
    Pediatr Res; 1988 Jan; 23(1):23-30. PubMed ID: 3340440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phospholipid binding and biophysical activity of pulmonary surfactant-associated protein (SAP)-35 and its non-collagenous COOH-terminal domains.
    Ross GF; Notter RH; Meuth J; Whitsett JA
    J Biol Chem; 1986 Oct; 261(30):14283-91. PubMed ID: 3021734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disparity between tidal and static volumes of immature lungs treated with reconstituted surfactants.
    Kobayashi T; Li WZ; Tashiro K; Takahashi R; Waseda Y; Yamamoto K; Suzuki Y
    J Appl Physiol (1985); 1996 Jan; 80(1):62-8. PubMed ID: 8847333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reconstitution of surfactant activity by using the 6 kDa apoprotein associated with pulmonary surfactant.
    Yu SH; Possmayer F
    Biochem J; 1986 May; 236(1):85-9. PubMed ID: 3098235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of exogenous surfactant in ventilated immature newborn rabbits.
    Kobayashi T; Curstedt T; Grossmann G; Robertson B
    Respir Physiol; 1989 Apr; 76(1):1-12. PubMed ID: 2727412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Combination of Short and Simple Surfactant Protein B and C Analogues as a New Synthetic Surfactant: In Vitro and Animal Experiments.
    Choi YS; Chung SH; Bae CW
    Yonsei Med J; 2017 Jul; 58(4):823-828. PubMed ID: 28540997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inactivation of exogenous surfactant by pulmonary edema fluid.
    Kobayashi T; Nitta K; Ganzuka M; Inui S; Grossmann G; Robertson B
    Pediatr Res; 1991 Apr; 29(4 Pt 1):353-6. PubMed ID: 1852528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-molecular-weight hydrophobic proteins from bovine pulmonary surfactant.
    Mathialagan N; Possmayer F
    Biochim Biophys Acta; 1990 Jul; 1045(2):121-7. PubMed ID: 2378907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Importance of hydrophobic apoproteins as constituents of clinical exogenous surfactants.
    Hall SB; Venkitaraman AR; Whitsett JA; Holm BA; Notter RH
    Am Rev Respir Dis; 1992 Jan; 145(1):24-30. PubMed ID: 1731593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.